Global liquid biopsy market to hit $7.05b by 2030

Tech advancements like next-generation sequencing drive the sector.

The global liquid biopsy market is expected to reach $7.05b by 2030 at a compound annual growth rate of 11.8%, according to MarketsandMarkets.

The sector’s expansion is attributed to the increasing incidence of cancer and a growing emphasis on early and precise disease detection.

“Technological advancements such as next-generation sequencing and improved biomarker detection methods are enhancing the sensitivity and reliability of liquid biopsy tests,” the report said.

Moreover,  rising investments in precision medicine and the increasing demand for early and non-invasive diagnostic solutions are further driving market growth.